Proteome Sciences PLC Capital Reinvestment Ratio
Proteome Sciences PLC capital reinvestment ratio. Proteome Sciences PLC (PRM) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow (GBX851.00K) in capital expenditures (GBX39.00K). Check PRM cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Proteome Sciences PLC (2010–2022)
Capital reinvestment ratio of Proteome Sciences PLC from 2010 to 2022. This chart tracks Proteome Sciences PLC's Capital Reinvestment Ratio across 6 annual periods. Also explore Proteome Sciences PLC (PRM) equity growth momentum to track the company's year-over-year net asset growth rate.
Proteome Sciences PLC Capital Reinvestment Ratio by Year (2010–2022)
Proteome Sciences PLC capital reinvestment ratio by year from 2010 to 2022. For the full cash flow conversion analysis, see Proteome Sciences PLC cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 815.89x | GBX2.14 Million | GBX1.75 Billion | ▼ -62.4% |
| 2021 | 2168.98x | GBX793.00K | GBX1.72 Billion | ▲ +159.3% |
| 2020 | 836.39x | GBX1.58 Million | GBX1.32 Billion | ▲ +3186498.5% |
| 2017 | 0.03x | GBX55.47 Billion | GBX1.46 Billion | ▼ -36.5% |
| 2015 | 0.04x | GBX46.63 Billion | GBX1.93 Billion | ▼ -73.8% |
| 2010 | 0.16x | GBX4.00 Million | GBX631.00K | — |